Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain
Status:
Withdrawn
Trial end date:
2019-02-28
Target enrollment:
Participant gender:
Summary
The investigators will test whether hypotonic (diluted) remodulin solution causes less pain
than the eutonic (undiluted) solution supplied by the manufacturer.